298 related articles for article (PubMed ID: 15055999)
1. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
[TBL] [Abstract][Full Text] [Related]
2. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.
Guillon J; Moreau S; Mouray E; Sinou V; Forfar I; Fabre SB; Desplat V; Millet P; Parzy D; Jarry C; Grellier P
Bioorg Med Chem; 2008 Oct; 16(20):9133-44. PubMed ID: 18819813
[TBL] [Abstract][Full Text] [Related]
3. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
Guillon J; Mouray E; Moreau S; Mullié C; Forfar I; Desplat V; Belisle-Fabre S; Pinaud N; Ravanello F; Le-Naour A; Léger JM; Gosmann G; Jarry C; Déléris G; Sonnet P; Grellier P
Eur J Med Chem; 2011 Jun; 46(6):2310-26. PubMed ID: 21458112
[TBL] [Abstract][Full Text] [Related]
4. Emergence of pyrido quinoxalines as new family of antimalarial agents.
Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.
Jonet A; Guillon J; Mullie C; Cohen A; Bentzinger G; Schneider J; Taudon N; Hutter S; Azas N; Moreau S; Savrimoutou S; Agnamey P; Dassonville-Klimpt A; Sonnet P
Med Chem; 2018; 14(3):293-303. PubMed ID: 28745231
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
Zarranz B; Jaso A; Aldana I; Monge A; Maurel S; Deharo E; Jullian V; Sauvain M
Arzneimittelforschung; 2005; 55(12):754-61. PubMed ID: 16430030
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.
Vicente E; Lima LM; Bongard E; Charnaud S; Villar R; Solano B; Burguete A; Perez-Silanes S; Aldana I; Vivas L; Monge A
Eur J Med Chem; 2008 Sep; 43(9):1903-10. PubMed ID: 18215443
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds.
van Heerden L; Cloete TT; Breytenbach JW; de Kock C; Smith PJ; Breytenbach JC; N'Da DD
Eur J Med Chem; 2012 Sep; 55():335-45. PubMed ID: 22889556
[TBL] [Abstract][Full Text] [Related]
9. Pyridinylquinoxalines and pyridinylpyridopyrazines as lead compounds for novel p38 alpha mitogen-activated protein kinase inhibitors.
Koch P; Jahns H; Schattel V; Goettert M; Laufer S
J Med Chem; 2010 Feb; 53(3):1128-37. PubMed ID: 20078117
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents.
Primas N; Suzanne P; Verhaeghe P; Hutter S; Kieffer C; Laget M; Cohen A; Broggi J; Lancelot JC; Lesnard A; Dallemagne P; Rathelot P; Rault S; Vanelle P; Azas N
Eur J Med Chem; 2014 Aug; 83():26-35. PubMed ID: 24946216
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors.
Vidaillac C; Guillon J; Moreau S; Arpin C; Lagardère A; Larrouture S; Dallemagne P; Caignard DH; Quentin C; Jarry C
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):620-31. PubMed ID: 18035830
[TBL] [Abstract][Full Text] [Related]
13. Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents.
Gnoatto SC; Susplugas S; Dalla Vechia L; Ferreira TB; Dassonville-Klimpt A; Zimmer KR; Demailly C; Da Nascimento S; Guillon J; Grellier P; Verli H; Gosmann G; Sonnet P
Bioorg Med Chem; 2008 Jan; 16(2):771-82. PubMed ID: 17967541
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antimalarial activity, and cellular toxicity of new arylpyrrolylaminoquinolines.
Casagrande M; Basilico N; Rusconi C; Taramelli D; Sparatore A
Bioorg Med Chem; 2010 Sep; 18(18):6625-33. PubMed ID: 20797868
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
Desplat V; Moreau S; Gay A; Fabre SB; Thiolat D; Massip S; Macky G; Godde F; Mossalayi D; Jarry C; Guillon J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):204-15. PubMed ID: 20222763
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C
J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials.
Rodrigues T; Guedes RC; dos Santos DJ; Carrasco M; Gut J; Rosenthal PJ; Moreira R; Lopes F
Bioorg Med Chem Lett; 2009 Jul; 19(13):3476-80. PubMed ID: 19467600
[TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of pyrrolo[1,2-a]quinoxalines.
Huang A; Liu F; Zhan C; Liu Y; Ma C
Org Biomol Chem; 2011 Nov; 9(21):7351-7. PubMed ID: 21894335
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
20. Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activity.
Taylor DK; Avery TD; Greatrex BW; Tiekink ER; Macreadie IG; Macreadie PI; Humphries AD; Kalkanidis M; Fox EN; Klonis N; Tilley L
J Med Chem; 2004 Mar; 47(7):1833-9. PubMed ID: 15027875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
